550 likes | 1.26k Views
Liver failure and jaundice. PBL support lecture. Topics. Physiology of jaundice Causes of obstructive jaundice Syndrome of hepatitis Syndrome of cirrhosis Causes of liver disease Viral hepatitides . To cover. Bilirubin metabolism in detail Clinical tests required
E N D
Liver failure and jaundice PBL support lecture
Topics • Physiology of jaundice • Causes of obstructive jaundice • Syndrome of hepatitis • Syndrome of cirrhosis • Causes of liver disease • Viral hepatitides
To cover • Bilirubin metabolism in detail • Clinical tests required • Imaging US/ MRCP/ ERCP • Liver screening blood tests • Detailed explanations symptoms physiology of • Ascites / Encephalopathy / HRS • Gallstone disease • Psychopathology related to alcohol • Alcohol histories and CAGE questionnaire
Key points • Formed as breakdown of haem • Conjugated in the liver • Water soluble • Extricated in the bile • Metabolised in the gut by bacteria • Reabsorbed and excreted in the liver
Causes • Haemolysis • Unconjugated • Hepatic • Assoc with signs of liver failure • Obstructive • Pale stools • Dark urine • Itch
Causes of obstructive jaundice • Obstruction • Within duct • In duct wall • Outside duct • Physiological
Causes of obstructive jaundice • CBD stones • Cancer • Head of pancreas • Cholangiocarcinoma • LN mets • Chronic pancreatitis • Sclerosing cholangitis
Definitions • What is hepatitis ? • Liver inflammation • Not “infection” (necessarily) • Acute vs chronic hepatitis ? • Inflammation persisting > 6 months • Generally useful for viral hepatitis • What is cirrhosis • Fibrosis of the liver • Nodule formation
Obsolete terms • Chronic persistent hepatitis • Chronic lobular hepatitis • Chronic active hepatitis • Replaced by “activity scores”
Hepatitis “map” Acute hepatitis Recovery Fulminant hepatitis Chronic hepatitis Death Transplantation Increasing fibrosis Cirrhosis
Acute hepatitis • Typically • Unwell • Jaundice • RUQ pain • Severe • Confusion • Coagulopathy
Blood tests in acute hepatitis • Typically • Raised ALT / AST (often >1,000) • High bilirubin • Severe cases • Coagulopathy • Renal impairment
Hepatitis “map” Acute hepatitis Recovery Fulminant hepatitis Chronic hepatitis Death Transplantation Increasing fibrosis Cirrhosis
Chronic hepatitis • Usually low grade inflammation of the liver • Symptoms • often none • Fatigue • Typically • abnormal LFTs (mild elevation ALT) • Screening • Presents with cirrhosis
Hepatitis “map” Acute hepatitis Recovery Fulminant hepatitis Chronic hepatitis Death Transplantation Increasing fibrosis Cirrhosis
Fulminant hepatitis • Acute hepatitis with liver failure • Encephalopathy within 28 days of jaundice • Poor prognosis often needs transplantation
Hepatitis “map” Acute hepatitis Recovery Fulminant hepatitis Chronic hepatitis Death Transplantation Increasing fibrosis Cirrhosis
Loss of function Jaundice Coagulopathy Decreased drug metabolism Decreased hormone metabolism Increased sepsis Portal hypertension Varices Piles Ascites Encephalopathy Renal failure Cirrhosis
Causes of cirrhosis • Hazardous Alcohol • Chronic hepatitis B + C • Autoimmune liver disease • Haemachromatosis • Wilson's disease • Chronic obstruction
Stigmata of cirrhosis • Palmer erythema • Leuconychia • Spider naevi • Caput medusa • etc
“cholestatic hepatitis” • Oxymoron • Typically drug induced • Acute illness similar to acute hepatitis • But LFTs “obstructive”
Hepatitis A • Duration - Chronicity • Modes of spread • Serology • Outcome
Hepatitis A 99% Acute hepatitis 1-2% Recovery Fulminant hepatitis Chronic hepatitis Death Transplantation Increasing fibrosis Cirrhosis
Hepatitis A • Faeco–oral spread • Endemic in developing world • Common in childhood • Typical 12 weeks duration • Immunisation possible • Travel • Other liver disease
Clinical illness Infection ALT IgM IgG Viremia Response HAV in stool 0 1 2 3 4 5 6 7 8 9 10 11 12 13 Week
Hepatitis B • Spread • Blood (IVDU, medical) • Sex • Vertical • Endemic in much of Africa and Asia • Worlds second biggest carcinogen • Immunisation
What determines progression to chronic infection • Age • <1year 90% chronic • 1-5 years 30% chronic • >5 years 1-5% chronic • Immunosuppression • Route of infection • Genotype
Hepatitis B 96% Acute hepatitis 1% 70% Recovery Fulminant hepatitis 30% 3% Chronic hepatitis Death Transplantation Increasing fibrosis Cancer Cirrhosis
Hepatitis B cirrhosis prognosis • Determined by rate of fibrosis progression • Biopsies scored • Fibrosis • Inflammatory activity
Acute Hepatitis B Virus Infection with Recovery Symptoms anti-HBe HBeAg Total anti-HBc Titre anti-HBs IgM anti-HBc HBsAg 0 4 8 12 16 24 28 32 52 100 20 36 Weeks after Exposure
Progression to Chronic Hepatitis B Virus Infection Acute (6 months) Chronic (Years) HBeAg anti-HBe HBsAg Total anti-HBc Titre IgM anti-HBc Years 0 4 8 16 20 24 28 36 12 32 52 Weeks after Exposure
Hepatitis B serology • Acute • Early rise in anti core IgM • Chronic • Persistent HbsAg >6/12 • HbeAg +ve = immunotolerant • High viral levels = infectious • Normal LFTs • Few liver problems • HbeAb +ve = immunoreactive • Low viral levels = less infectious • ALT raised • Often fibrotic / cirrhotic
Hepatitis B treatment • Acute - none necessary • Chronic • Antiviral • Suppression • ?? duration • Interferon • Immune stimulation
Hepatitis C • Transmission • Blood borne • Medical • IVDU • 10-20% cases no risk factor • (sexual) • (vertical) • No immunisation possible
Hepatitis C 25% Acute hepatitis Recovery Fulminant hepatitis 75% Chronic hepatitis Death Transplantation Increasing fibrosis Cirrhosis
Hepatitis C • Rarely causes symptoms • Screening of • Donors • IVDU • Abnormal LFTs • Testing • Antibodies • PCR
Treatment • Interferon • Based on genotype • Ribavirin
Hepatitis E • Virtually identical to hepatitis A • May cause severe disease in pregnancy
Hepatitis delta • Imperfect virus • No symptoms of its own • Worsens prognosis of hepatitis B • Treat hepatitis B